- The trend backdrop is active with a 44-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6446
TAI
Week ended 07 Aug 2026
Weekly Investor Report
PharmaEssentia Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
1,240 TWD
17.0%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 59.9% above the Trend Line and sits at 82.9% of its 52-week range. The latest completed week returned 17.0%, after a -3.5% four-week move. The latest news-sentiment score is 50/100.
Setup score
70
out of 100
Latest Close
1,240 TWD
7 Aug 2026
1W Return
17.0%
latest completed week
4W Return
-3.5%
short-term follow-through
12W Return
66.7%
quarterly tape
Trend Breadth
84.6%
44 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
17.0%
Latest completed week; four-week move -3.5%.
Indicator stack
92/64
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 59.9% above the Trend Line and sits at 82.9% of its 52-week range. The latest completed week returned 17.0%, after a -3.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9812-week average 0.89
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.5% over four weeks, 66.7% over 12 weeks, and 201.6% over one year. The current trend has remained active for 44 consecutive weeks.
Performance by holding period
Active trend streak44 weeks
Active weeks in one year44
Trend breadth84.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.95Latest activity-pressure read.
Pressure change-41.7%Four-week change in activity pressure.
Leadership51.73Latest relative-leadership reading.
RS change-12.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.3%Distance below the 52-week high.
13-week volatility9.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+20.8%Week of 3 Jul.
Worst week-7.0%Week of 17 Jul.
Latest week+17.0%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks1
Modest losses5
Sharp losses6
Recent vol9.2%13-week weekly-return volatility.
Base vol7.4%52-week weekly-return volatility.
Up/down split28/23Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank30 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank8 / 13
Group average-3.1%
Trend breadth23.1%
Trend23.1%active weekly trend signals
MD53.8%positive activity pressure
RS7.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape69/100
Trend, activity pressure, participation, and risk combine to a 69/100 tape read.
Indicator analysis90/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.
Activity pressure 0.98; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,240 TWD | 17.0% | 775.7 TWD | 473.3 TWD | 0.95 | 51.73 | 18.6M | On |
| 31 Jul 2026 | 1,060 TWD | -6.6% | 749.2 TWD | 467.1 TWD | 1.11 | 34.50 | 14.5M | On |
| 24 Jul 2026 | 1,135 TWD | -5.0% | 728.6 TWD | 462.2 TWD | 1.39 | 43.26 | 11.0M | On |
| 17 Jul 2026 | 1,195 TWD | -7.0% | 705.6 TWD | 456.7 TWD | 1.60 | 55.47 | 16.6M | On |
| 10 Jul 2026 | 1,285 TWD | 2.3% | 680.8 TWD | 450.9 TWD | 1.64 | 58.80 | 17.3M | On |
| 3 Jul 2026 | 1,256 TWD | 20.8% | 653.4 TWD | 444.4 TWD | 1.66 | 51.97 | 17.7M | On |
| 26 Jun 2026 | 1,040 TWD | 9.0% | 627.0 TWD | 438.1 TWD | 1.57 | 33.11 | 14.2M | On |
| 19 Jun 2026 | 954.5 TWD | 11.7% | 606.4 TWD | 433.1 TWD | 1.49 | 17.72 | 9.7M | On |
| 12 Jun 2026 | 854.6 TWD | 1.3% | 589.0 TWD | 428.8 TWD | 1.25 | 10.97 | 21.5M | On |
| 5 Jun 2026 | 843.8 TWD | 0.8% | 575.5 TWD | 425.1 TWD | 0.98 | 7.42 | 16.4M | On |
| 29 May 2026 | 837.5 TWD | 14.8% | 562.4 TWD | 421.4 TWD | 0.62 | 7.39 | 19.9M | On |
| 22 May 2026 | 729.4 TWD | -1.9% | 549.5 TWD | 417.7 TWD | 0.16 | -1.01 | 15.4M | On |
| 15 May 2026 | 743.8 TWD | 14.1% | 540.7 TWD | 414.8 TWD | -0.12 | 3.49 | 28.9M | On |
| 8 May 2026 | 652.0 TWD | 9.5% | 532.0 TWD | 412.0 TWD | -0.34 | -10.42 | 13.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.